Prevention and treatment of osteoporosis

[1]  Estrogen and coronary heart disease in women. , 1991 .

[2]  L. Hedlund,et al.  Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  G. Beaupré,et al.  Effects of fluoride treatment on bone strength , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  R. Pattison,et al.  Investor-owned and not-for-profit hospitals. A comparison based on California data. , 1983, The New England journal of medicine.

[5]  M. Burritt,et al.  Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. , 1992, Clinical science.

[6]  R. Lindsay,et al.  The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss , 1984, Obstetrics and gynecology.

[7]  C. Slemenda,et al.  Calcium supplementation and increases in bone mineral density in children. , 1992, The New England journal of medicine.

[8]  R. Lindsay,et al.  Calcium Homeostasis of an Elderly Population upon Admission to a Nursing Home , 1993, Journal of the American Geriatrics Society.

[9]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Mysiw,et al.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[11]  J. Reginster,et al.  1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN , 1987, The Lancet.

[12]  K. Yano,et al.  Thiazide effect on the mineral content of bone. , 1983, The New England journal of medicine.

[13]  W. Nelp,et al.  Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. , 1983, Metabolism: clinical and experimental.

[14]  Avioli Lv.  Calcitonin therapy in osteoporotic syndromes. , 1990 .

[15]  G. Rodan,et al.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. , 1991, The Journal of clinical investigation.

[16]  R. Heaney,et al.  Nutritional factors in osteoporosis. , 1993, Annual review of nutrition.

[17]  B. Hulka.  Hormone‐replacement therapy and the risk of breast cancer , 1990, CA: a cancer journal for clinicians.

[18]  B. Dawson-Hughes,et al.  A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. , 1990 .

[19]  R. Lindsay,et al.  Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. , 1978, Clinical science and molecular medicine.

[20]  E. Siris,et al.  Effects of tamoxifen on spinal bone density in women with breast cancer. , 1989, Journal of the National Cancer Institute.

[21]  R. Lindsay,et al.  Estrogen treatment of patients with established postmenopausal osteoporosis , 1990, Obstetrics and gynecology.

[22]  S. Ott,et al.  Calcitriol treatment is not effective in postmenopausal osteoporosis. , 1989, Annals of internal medicine.

[23]  J Reeve,et al.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. , 1980, British medical journal.

[24]  L. Joseph Melton,et al.  LONG-TERM USE OF THIAZIDE DIURETICS AND RISK OF HIP FRACTURE , 1989, The Lancet.

[25]  J. Parker,et al.  Maternal Weight Gain in Women With Good Pregnancy Outcome , 1990, Obstetrics and gynecology.

[26]  M. Whitehead,et al.  Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women , 1990, The Lancet.

[27]  P. Delmas,et al.  Treatment of vertebral osteoporosis with disodium monofluorophosphate: Comparison with sodium fluoride , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  I. Reid,et al.  Effect of calcium supplementation on bone loss in postmenopausal women. , 1993, The New England journal of medicine.

[29]  François Duboeuf,et al.  Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1992 .

[30]  R. Lindsay,et al.  The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. , 1990, The Journal of clinical endocrinology and metabolism.

[31]  A. Prost,et al.  RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS , 1988, The Lancet.

[32]  William M. O'Fallon,et al.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. , 1990 .

[33]  G. Belle,et al.  Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer , 1991, The Lancet.